M B Rietberg1, E E H Van Wegen, G Kwakkel. 1. Department Rehabilitation Medicine, section Physical therapy, Research Institute MOVE,VU University Medical Center, The Netherlands. m.rietberg@vumc.nl
Abstract
PURPOSE: To determine the reproducibility, responsiveness and concurrent validity of Dutch versions of the Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), and Checklist Individual Strength (CIS20R) in patients with multiple sclerosis (MS). METHOD: Forthy-three ambulatory patients with MS (mean age 48.7 years; SD 7 years; 30 women; median Expanded Disability Status Scale score 3.5) completed the questionnaires twice within 1 week. The Intraclass Correlation Coefficients (ICCs), Bland and Altman analysis, the smallest detectable change (SDC) and the minimal detectable change (MDC) were calculated. Concurrent validity was determined by Pearson's correlation coefficients. RESULTS: ICCs ranged from 0.76 (FSS), to 0.85 (MFIS) to 0.81 (CIS20R). Bland and Altman analysis showed no significant systematic differences between assessments. MDCs were 20.7% (FSS), 19.23% (MFIS), and 17.7% (CIS20R). Pearson correlation coefficients were r = 0.66 (FSS-MFIS), r = 0.54 (MFIS-CIS20R) and r = 0.42 (CIS20R-FSS). CONCLUSION: Despite good test-retest reliability of FSS, MFIS and the CIS20R, the present study shows that fatigue questionnaires are not very responsive for change in patients with MS. This finding suggests that future trials should monitor profiles of fatigue by repeated measurements rather than pre-post assessments alone. The moderate associations suggest that the three questionnaires largely measure different aspects of perceived fatigue.
PURPOSE: To determine the reproducibility, responsiveness and concurrent validity of Dutch versions of the Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), and Checklist Individual Strength (CIS20R) in patients with multiple sclerosis (MS). METHOD: Forthy-three ambulatory patients with MS (mean age 48.7 years; SD 7 years; 30 women; median Expanded Disability Status Scale score 3.5) completed the questionnaires twice within 1 week. The Intraclass Correlation Coefficients (ICCs), Bland and Altman analysis, the smallest detectable change (SDC) and the minimal detectable change (MDC) were calculated. Concurrent validity was determined by Pearson's correlation coefficients. RESULTS: ICCs ranged from 0.76 (FSS), to 0.85 (MFIS) to 0.81 (CIS20R). Bland and Altman analysis showed no significant systematic differences between assessments. MDCs were 20.7% (FSS), 19.23% (MFIS), and 17.7% (CIS20R). Pearson correlation coefficients were r = 0.66 (FSS-MFIS), r = 0.54 (MFIS-CIS20R) and r = 0.42 (CIS20R-FSS). CONCLUSION: Despite good test-retest reliability of FSS, MFIS and the CIS20R, the present study shows that fatigue questionnaires are not very responsive for change in patients with MS. This finding suggests that future trials should monitor profiles of fatigue by repeated measurements rather than pre-post assessments alone. The moderate associations suggest that the three questionnaires largely measure different aspects of perceived fatigue.
Authors: Marcin K Uszynski; Matthew P Herring; Blathin Casey; Sara Hayes; Stephen Gallagher; Robert W Motl; Susan Coote Journal: Int J Behav Med Date: 2018-04
Authors: Daphne Kos; Inge van Eupen; Jill Meirte; Deborah Van Cauwenbergh; Greta Moorkens; Mira Meeus; Jo Nijs Journal: Am J Occup Ther Date: 2015 Sep-Oct
Authors: Anne Arewasikporn; Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Dawn M Ehde Journal: Health Psychol Date: 2018-04-19 Impact factor: 4.267
Authors: Elahe Kazemeini; Marc J Braem; Greta Moorkens; Sowjanya Balina; Chloé Kastoer; Sara Op de Beeck; Olivier M Vanderveken; Marijke Dieltjens Journal: J Clin Sleep Med Date: 2019-04-15 Impact factor: 4.062
Authors: Roy G Elbers; Marc B Rietberg; Erwin E H van Wegen; John Verhoef; Sharon F Kramer; Caroline B Terwee; Gert Kwakkel Journal: Qual Life Res Date: 2011-10-20 Impact factor: 4.147
Authors: Ka-Hoo Lam; James Twose; Hannah McConchie; Giovanni Licitra; Kim Meijer; Lodewijk de Ruiter; Zoë van Lierop; Bastiaan Moraal; Frederik Barkhof; Bernard Uitdehaag; Vincent de Groot; Joep Killestein Journal: Eur J Neurol Date: 2021-11-14 Impact factor: 6.288